Literature DB >> 23560244

A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities.

Bruce Shiramizu1, Cris Milne, Kevin Terada, Kevin Cassel, Rayna K Matsuno, Jeffery Killeen, Chin-Yuan Liang, Faye Tachibana, Tom Sheeran, James Weihe, Marc T Goodman.   

Abstract

OBJECTIVE: Disparities in anal cancer incidence among Hawaii's HIV-infected minority population is an emerging health concern. Although anal cytology/anoscopy are effective anal cancer screening tools, social barriers exist that prevent individuals from seeking appropriate care.
DESIGN: Community based participatory research (CBPR) principles were applied to develop resources, including testing a self-obtained anal specimen procedure, to increase anal cancer screening among Hawaii's underserved/ minority populations.
METHODS: A team of community members, academic researchers, and health care providers developed culturally-sensitive educational/recruitment materials regarding anal cancer risk targeting underserved/minority HIV-infected individuals. Self- and health care provider (HCP)-obtained anal cancer screening specimens were reviewed for cytology and tested for human papillomavirus DNA. A follow-up evaluation elicited feedback on attitudes and experiences.
RESULTS: Community discussion sessions identified key messages about anal cancer, anal cancer screening, and HPV infection for materials and were used, that successfully recruited 46 individuals (38 males/8 females; 9 Native Hawaiians/Pacific Islanders/Asians, 2 Blacks, 6 Hispanics, 6 American Indian/Alaskan Natives, 23 Whites). Concordance in cytology results between self- and HCP-obtained specimens was moderated (kappa=0.37) with the perception that the self-obtained specimen procedure was private (93%), safe (100%), and easy to manage (100%); and a majority (92%) willing to use the self-obtained method again.
CONCLUSIONS: CBPR was a practical approach in engaging Hawaii's HIV-infected minority participation in anal cancer screening research. Community outreach and recruitment efforts suggested that self-obtained screening specimens could be an acceptable and effective means to reach Hawaii's HIV-infected ethnic minorities.

Entities:  

Keywords:  Anal dysplasia; Anal neoplasia; Human immunodeficiency virus; Human papillomavirus

Year:  2012        PMID: 23560244      PMCID: PMC3614361          DOI: 10.4172/2155-6113.1000162

Source DB:  PubMed          Journal:  J AIDS Clin Res


  24 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Treatment adherence among Native Hawaiians living with HIV.

Authors:  Lana Sue L Ka'opua; Charles W Mueller
Journal:  Soc Work       Date:  2004-01

3.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

Review 4.  The role of viruses and sexual transmission in anal cancer.

Authors:  Ruth Dunleavey
Journal:  Nurs Times       Date:  2005 Mar 1-7

5.  Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.

Authors:  Nancy F Crum-Cianflone; Katherine Huppler Hullsiek; Vincent C Marconi; Anuradha Ganesan; Amy Weintrob; Robert V Barthel; Brian K Agan
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

Review 6.  Human papilloma viruses and cancer in the post-vaccine era.

Authors:  E Galani; C Christodoulou
Journal:  Clin Microbiol Infect       Date:  2009-11       Impact factor: 8.067

7.  Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men.

Authors:  Ross D Cranston; Teresa M Darragh; Elizabeth A Holly; Naomi Jay; J Michael Berry; Maria Da Costa; Jimmy T Efird; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-01       Impact factor: 3.731

Review 8.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Authors:  Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

Review 9.  Human papillomavirus vaccines and anal carcinoma.

Authors:  Silvia Franceschi; Hugo De Vuyst
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

10.  Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men.

Authors:  Thomas M Lampinen; Mary Lou Miller; Keith Chan; Aranka Anema; Dirk van Niekerk; Arn J Schilder; Robert Taylor; Robert S Hogg
Journal:  Cytojournal       Date:  2006-03-20       Impact factor: 2.091

View more
  3 in total

1.  Results of the Women's Self-Performed Anal Pap Trial in Human Immunodeficiency Virus-Infected Women.

Authors:  Candice J McNeil; Christina S Kong; Andrew Anglemyer; Vivian Levy; Yvonne Maldonado
Journal:  Sex Transm Dis       Date:  2016-07       Impact factor: 2.830

2.  Addressing Risk and Reluctance at the Nexus of HIV and Anal Cancer Screening.

Authors:  Lana Sue I Ka'opua; Kevin Cassel; Bruce Shiramizu; Rebecca L Stotzer; Andrew Robles; Cathy Kapua; Malulani Orton; Cris Milne; Maddalynn Sesepasara
Journal:  Health Promot Pract       Date:  2015-12-02

3.  Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening.

Authors:  Alan G Nyitray; Vanessa Schick; Michael D Swartz; Anna R Giuliano; Maria E Fernandez; Ashish A Deshmukh; Timothy J Ridolfi; Christopher Ajala; Bridgett Brzezinski; Micaela Sandoval; Belinda Nedjai; Jennifer S Smith; Elizabeth Y Chiao
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.